Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

NCT04167813 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT04167813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04167813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Ondansetron as a Parkinson's HAllucinations Treatment
Lead sponsor
University College, London
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2021
Completion date
August 30, 2024
Enrollment
168 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies, parkinson's hallucinations